7 November 2016
2QFY17 Results Update | Sector: Retail
Shoppers Stop
Neutral
BSE SENSEX
25,230
Bloomberg
Equity Shares (m)
M.Cap.(INRb)/(USDb)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
Avg Val, INRm/ Vol m
Free float (%)
S&P CNX
7,747
SHOP IN
83.5
28.7 / 0.5
422 / 335
-4/-12/-14
12
32.9
CMP: INR349
TP: INR350 (0%)
Weak margin performance continues
S/L results:
Shoppers Stop’s (SHOP) sales grew 7.1% YoY (est. of +18%) to
INR9.4b (Ind-AS). On LTL basis, sales grew 2.2% (on a base of 0.1% growth) with
volumes down 3.1%. For stores less than five years/over five years old, LTL sales
grew 5.9%/0.5%. EBITDA declined 19.3% YoY (est. of +9.4%) to INR330m,
leading to adj. PAT of INR107m (-11% YoY).
Gross margin flat at 36%.
Increase in staff costs (+50bp YoY to 7.2%), lease rent
(+50bp YoY to 9.4%) and administrative expenses (+20bp YoY to 15.8%) led to
EBITDA margin contraction of 120bp YoY to 3.5% (est. of -50bp). EBITDA
declined 19.3% YoY to INR330m. Adj. PAT decline was limited to 11% YoY due to
lower depreciation and lower tax rate than expected. In 2QFY17, SHOP opened
one new store.
HyperCITY performance highlights:
HyperCITY reported sales of INR2.9b, up
15.5% YoY (LTL sales/volume growth of 3.4%/2.7%). Net margin expanded
100bp YoY to 21.2%. Store EBITDA declined to INR19m from INR55m in 2QFY16,
led by higher store operating expenses (+28.1% YoY). HyperCITY posted EBITDA
and PAT loss of INR6m and 173m, respectively.
Concall highlights:
a) FY17 target SSS of 5.5% for SHOP and 6-7% for 2HFY17; for
HyperCITY, it would be early double-digit for H2FY17. b) Started 2QFY17 (end of
season sale phase of the quarter) with double-digit LTL growth; latter part went
bad. Diwali to Diwali comparison was 8-9% LTL growth. c) Company-level
EBITDA margin guidance of 6-6.5%. d) Decent pick up in October (late single-
digit SSS growth to early double-digit); November might be a drag to 3QFY17,
while December is likely to be same as October.
Valuation and view:
Good start to the festive season will aid healthy growth in
2HFY17, but results continue to be disappointing. We cut our SSS estimate for
FY17; however, due to increase in other income, we have increased EPS by 5-6%
for FY17E/FY18E. Maintain
Neutral
with a SOTP-based TP of INR350.
Financials & Valuations (INR b)
Y/E Mar
2016 2017E 2018E
Net Sales
34.1
37.2
43.2
EBITDA
2.2
2.3
2.9
PAT
0.5
0.8
1.0
EPS (INR)
5.8
9.3
12.0
Gr. (%)
19.3
58.8
29.4
BV/Sh (INR)
95.6 107.4 119.6
RoE (%)
6.3
9.3
10.7
RoCE (%)
6.2
7.9
9.1
P/E (x)
59.8
37.6
29.1
P/BV (x)
3.6
3.2
2.9
Estimate change
TP change
Rating change
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.
Krishnan Sambamoorthy
(Krishnan.Sambamoorthy@MotilalOswal.com); +91 22 3982 5428
Vishal Punmiya
(Vishal.Punmiya@MotilalOswal.com); +91 22 3980 4261